DANIELS ERIC JOSEPH (Chief Development Officer) received a stock award from KIORA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/2/2025ACC: 0001372514-25-000035
Officer· Chief Development Officer
Since Oct 2021
+23.32K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
23.32K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.77K
Price / share
—
Trade value
—
% of position
41.8%
4/1/2025
18.60K→26.38K
Total
Net shares
+7.77K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2025 | A · Award | +7.77K | — | — | 41.8% | 18.60K | 26.38K |
| Total | +7.77K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
15.54K shares
Shares
+15.54K
Strike price
2.93
Held after
15.54K
Exercisable
—
4/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock15.54K shares | 4/1/2025 | A · Award | +15.54K | 2.93 | — | 15.54K |